The influenza virus is a member of the Orthomyxoviridae family of segmented, single-stranded, negatively charged RNA viruses. Three different influenza virus types—A, B, and C—are included in this group. The type A viruses infect both domesticated and wild birds, horses, swine, other mammals, and humans, while the type B and C viruses only affect humans.In the United States, seasonal epidemics of disease are brought on by human influenza A and B viruses almost every winter. An influenza pandemic can be brought on by the spread of a brand-new, radically different influenza virus. Infections with influenza type C are thought to only cause a mild respiratory illness and not epidemics. Each virus subtype has undergone mutation, resulting in a variety of strains with various levels of pathogenicity; some are pathogenic to one species but not to others, and some are pathogenic to several.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V52580 | Trifluoperazine-d3 dihydrochloride | 1432064-02-2 | Trifluoperazine-d3 (di-HCl) is the deuterated form of Trifluoperazine (di-HCl). |
|
V54354 | Trifluoromethyl-tubercidin (TFMT) | 1854086-05-7 | Triflumethyl-tubercidin (TFMT) is a 2'-O-ribose methyltransferase 1 (MTr1) inhibitor that limits influenza virus replication by interacting with its S-adenosyl-L-methionine binding pocket. |
|
V21476 | Umifenovir | 131707-25-0 | Umifenovir (trade name Arbidol) is a broad-spectrum antiviral drug that inhibits viral fusion, and has been approved for use in Russia and China for the treatment of influenza and other respiratory viral infections. |
|
V2388 | Umifenovir (Arbidol) HCl | 131707-23-8 | Umifenovir (trade name Arbidol) HCl, the hydrochloride salt of umifenovir, is a broad-spectrum antiviral drug that blocks viral fusion, and was approved for use in Russia and China for the treatment of influenza and other respiratory viral infections. |
|
V54356 | Urumin | 2215863-74-2 | Urumin has antiviral effect against human influenza A virus. |
|
V28136 | VX-787 (Pimodivir) | 1629869-44-8 | Pimodivir (formerly VX787; JNJ872; VRT-0928787;VX-787; JNJ-872) is a novel and orally bioavailable inhibitor of influenza virus replication by blocking the PB2 cap-snatching activity of the influenza viral polymerase complex. |
|
V76065 | XSJ2-46 | 2265911-12-2 | XSJ2-46, a 5'-aminoNI analog, is an antiviral compound. |
|
V54349 | Yadanziolide B | 95258-13-2 | Yadanziolide B is a natural quasinoid compound that is a potential H5N1 neuraminidase inhibitor. |
|
V20639 | Zanamivir | 139110-80-8 | Zanamivir (GR-121167X; GG-167; Relenza) is a novel and potent neuraminidase inhibitor with antiviral activity againstinfluenza. |
|
V54335 | Zanamivir-Cholesterol Conjugate | 2478446-18-1 | Zanamivir–cholesterol conjugate is a long-acting neuraminidase inhibitor (antagonist) with potent efficacy against drug-resistant influenza viruses. |
|
V35103 | Zapnometinib (PD0184264; ATR-002) | 303175-44-2 | Zapnometinib (PD0184264), the bioactive metabolite of CI-1040, is a MEK inhibitor (antagonist) with IC50 of 5.7 nM. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
